Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain

Cell Transplantation

Volumn 8, Issue 1, 1999, Pages 47-58

  Emerich, Dwaine F ^a   Tracy, Mark A ^a   Ward, Kevin L ^a   Figueiredo, Maria ^a   Qian, Rulin ^a   Henschel, Carroll ^a   Bartus, Raymond T ^a  

^a ALKERMES INC   (United States)

Author keywords

Astrocyte; GFAP; Microsphere; Polymer; Sustained release

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICROSPHERE; POLYGLACTIN; POLYMER; SUTURE MATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BRAIN CORTEX; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0032819687     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368979900800114     Document Type: Article

References (42)

1. Austin, P. E. Subcuticular sutures and the rate of inflammation in noncontaminated wounds. Ann. Emerg. Med. 25:328-330; 1995.
2. Bartus, R. T.; Tracy, M. A.; Emerich, D. F.; Zale, S. E. Sustained delivery of proteins for novel therapeutic products. Science 21:1161-1162; 1998.
3. Beck, L. R.; Pope, V. Z. Evaluation of a new three month contraceptive microsphere system in primates. J. Contracept. Deliv. Syst. 1:79-82; 1980.
4. Becker, J. B.; Robinson, T.; Barton, T.; Sintov, A.; Siden, R.; Levy, R. J. Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled release of dopamine from the silicone polymer pellet placed into the denervated striatum. Brain Res. 508:60-64; 1990.
5. Brem, H. Polymers to treat brain tumors. Biomaterials 11: 699-701; 1990.
6. Brem, H.; Mahaley, M. S.; Vick, N. A.; Black, K. L.; Schold, S. C.; Eller, T. W.; Cozzens, J. W.; Kenealy, J. N. Interstitial chemotherapy with drug polymer implant for the treatment of recurrent gliomas. J. Neurosurg. 74: 441-446; 1991.
7. Brem, H.; Piantadosi, S.; Burger, P. C.; Walker, M.; Selker, R.; Vick, N. A.; Black, K.; Sisti, M.; Brem, S.; Mohr, G.; Muller, P.; Morawetz, R.; Schold, R. Placebo-controlled trials of safety and efficacy of intraoperative controlled delivery by biodegradadable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012; 1995.
8. Camarata, P. J.; Suryanarayanan, R.; Turner, D. A.; Parker, R. G.; Ebner, T. J. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 30:313-319; 1992.
9. Cavanagh, J. B. The proliferation of astrocytes around a needle wound in the rat brain. J. Anat. 106:471-487; 1970.
10. Chen, W.; He, J.; Olson, J.; Lu, D. R. Carboplatin-loaded PLGA microspheres for intracerebral implantation: In vivo characterization. Drug Delivery 4:301-311; 1997.
11. During, M. J.; Freese, A.; Sabel, B. A.; Saltzman, W. M.; Deutch, A.; Roth, R. H.; Ranger, R. S. Controlled release of dopamine from a polymeric brain implant: In vivo characterization. Ann. Neuol. 25:351-356; 1989.
12. Emerich, D. F.; Winn, S. R.; Harper, J.; Hammang, J. P.; Baetge, E. E.; Kordower, J. H. Implants of polymerencapsulated human NGF-secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. 349:148-164; 1994.
13. Grossman, S. A.; Reinhar, D. C.; Colvin, O. M.; Chasin, M.; Brundrett, R.; Tamargo, R. J.; Brem, H. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J. Neurosurg. 76:640-647; 1992.
14. Harbaugh, R.E.; Saunders, R.K.; Reeder, R.F. Use of implantable pumps for central nervous system drug infusions to treat neurological disease. Neurosurgery 23:693-698; 1988.
15. Hoffman, D.; Wahlberg, L.; Aebischer, P. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp. Neurol. 110:39-44; 1990.
16. Howard, M. A.; Gross, A.; Grady, M. S.; Langer, R. S.; Mathiowitz, E.; Winn, S. R.; Mayberg, M. R. Intracerebral drug delivery in rat with lesion-induced memory deficits. J. Neurosurg. 71:105-112; 1989.
17. Hutchinson, F. G.; Furr, B. G. A. Biodegradable polymers for sustained release of peptides. Biochem. Soc. Trans. 13: 520-523; 1985.
18. Johnson, O. L.; Cleland, J. L.; Lee, H. J.; Charnis, M.; Duenas, E.; Jaworowicz, W.; Shepard, D.; Shahzamani, A.; Jones, A. J. S.; Putney, S. D. A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 2:795-799; 1996.
19. Jordan, F. L.; Thomas, W. E. Brain macrophages; questions of origin and interrelationship. Brain Res. Rev. 13: 165-178; 1988.
20. Kou, J. H.; Emmet, C.; Shen, P.; Aswani, S.; Iwamoto, T.; Vaghefi, F.; Sanders, L. Brain biocompatibility of poly(D,L-lactic acid-co-glycolic acid) implants. Pharmaceut. Res. Suppl. 12:S-194; 1995.
21. Ludwin, S. K. Reaction of the ogliodendrites and astrocytes to trauma and implantation. A combined audoradiographic and immunohistochemical study. Lab. Invest. 52: 20-30; 1985.
22. Mathewson, A. J.; Berry, M. Observations on the astrocyte response to a cerebral stab wound in adult rats. Brain Res. 327:61-69; 1984.
23. Maysinger, D.; Jalsenjak, V.; Stolnik, S.; Garofalo, L.; Cuello, A. C.; Jalsenjak, I. Microencapsulated inonosialoganglioside GM1: Physical properites and in vivo effect. J. Microencapsul. 6:35-42; 1989.
24. McRae-Deguerce, A.; Hjorth S.; Dillon D. L.; Mason, D. W.; Tice, R. Implantable microencapsulated dopamine (DA): A new approach for slow-release DA delivery into brain tissue. Neurosci. Lett. 92:303-309; 1988.
25. Menei, P.; Daniel, V.; Montero-Menei, C.; Brouillard, M.; Pouplard-Barthelaix, A.; Benoit, J. P. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 14:470-478; 1993.
26. Mittal, S.; Cohen, A.; Maysinger, D. In vitro effects of brain-derived neurotrophic factor released from microspheres. Neuroreport 5:2577-2582; 1994.
27. Ogawa, Y.; Okada H.; Yamamota, M.; Shimamoto, T. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or co-poly (lactic/glycolic) acids and in vivo degradation of these polymers. Chem. Pharm. Bull. 36: 2576-2581; 1988.
28. Pardridge, W. M. Overview of brain drug delivery. Adv. Drug Deliv. Rev. 15:1-3; 1995.
29. Pardridge, W. M. CNS drug design based on principles of blood-brain barrier transport. J. Neurochem. 70:1781-1792; 1998.
30. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1986.
31. Pihlajamaki, H.; Botsman, O.; Hirvensalo, E.; Tormala, P.; Rokkanen, P. Absorbale pins of self-reinforced poly-L-lactic acid for fixation of fractures and osteomies. J. Bone Joint Surg. 74:853-857; 1992.
32. Pitt, G. C.; Marks, A.; Schindler, A. Biodegradable drug delivery systems based on aliphatic polymers: Application to contraceptives and narcotic antagonists. In: Baker, R. W., ed. Controlled release of bioactive agents. New York: Academic Press; 1980:19-43.
33. Reinhard, C. S.; Radomsky, M. L.; Saltzman, W. M.; Hilton, J.; Brem, H. Polymeric controlled release of dexamethasone in normal rat brain. J. Controlled Rel. 16:331-340; 1991.
34. Sanders, L. M.; Kell, B. A.; McRae, G. I.; Whitehead, G. W. Prolonged controlled release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: Influence of composition and molecular weight of polymer. J. Pharm. Sci. 75:365-360; 1986.
35. Spenlehauer, G.; Vert, M.; Benoit, J. P.; Boddaert, A. In vitro and in vivo degradation of poly(D,L lactide: glycolide) type microspheres made by solvent evaporation method. Biomaterials 10:557-563; 1989.
36. Tamargo, J. R.; Sills, A. K.; Reinhard, C. S.; Pinn, M. L.; Long, D. M.; Brem, H. Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema. J. Neurosurg. 74:956-961; 1991.
37. Tracy, M. A.; Ward, K. L.; Firouzabadian, L.; Wang, Y.; Dong, N.; Qian, R.; Zhang, Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials (in press).
38. Vissher, G. E.; Robinson, R. L.; Maulding, H. V.; Fong, J. W.; Pearson, J. E.; Argentieri, G. J. Biodegradation of and tissue reaction to 50:50 poly(D,L lactide: glycolide) microcapsules. J. Biomed. Mater. Res. 19:349-365; 1985.
39. Walter, K. A.; Tamargo, R. J.; Olivi, A.; Burger, P. C.; Brem, H. Intratumoral chemotherapy. Neurosurgery 37: 1129-1145; 1995.
40. Winde, G. Clinical and functional results of rectopexy with absorbable mesh-graft for treatment of complete rectal prolapse. Eur. J. Surg. 159:301-305; 1993.
41. Winn, S. R.; Wahlberg, L.; Tresco, P. A.; Aebischer, P. An encapsulated dopamine-releasing polymer alleviates experimental Parkinsonism in rats. Exp. Neurol. 105:244-250; 1989.
42. Wise, D. L.; Jackanics, T. M.; Nash, H. A.; Gregory, J. B. Polylactic acid as a biodegradable carrier for contraceptive steroids. Contraception 8:227-234; 1973.